Klaipeda Seamen's Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials

Phase

• Phase 33 trials

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• InDex Pharmaceuticals1 trial

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source